Why Newer Migraine Blockers Fail Some Patients

by | Jul 15, 2019 | Migraine | 0 comments

Research in an animal model of headache suggests that different underlying mechanisms at work in migraine may explain why some calcitonin gene-related peptide inhibitors, such as fremanezumab, may not work for everyone.

Read more here.

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pin It on Pinterest